Legacy Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,371
Closed -$316K 93
2025
Q1
$316K Buy
3,371
+659
+24% +$59K 0.03% 316
2024
Q4
$247K Buy
2,712
+103
+4% +$9.83K 0.02% 344
2024
Q3
$271K Buy
2,609
+141
+6% +$14.4K 0.03% 309
2024
Q2
$239K Buy
2,468
+179
+8% +$16.5K 0.03% 288
2024
Q1
$206K Sell
2,289
-411
-15% -$34.8K 0.03% 299
2023
Q4
$215K Sell
2,700
-1,272
-32% -$95.6K 0.03% 288
2023
Q3
$282K Sell
3,972
-16
-0.4% -$1.2K 0.05% 237
2023
Q2
$307K Sell
3,988
-823
-17% -$63.7K 0.05% 217
2023
Q1
$362K Buy
4,811
+154
+3% +$11.5K 0.07% 182
2022
Q4
$367K Buy
4,657
+275
+6% +$20.6K 0.07% 174
2022
Q3
$308K Buy
4,382
+106
+2% +$8.31K 0.07% 171
2022
Q2
$343K Buy
4,276
+698
+20% +$54.6K 0.07% 157
2022
Q1
$271K Buy
+3,578
New +$283K 0.05% 174
2019
Q3
Sell
-1,987
Closed -$142K 157
2019
Q2
$142K Buy
1,987
+900
+83% +$63.9K 0.1% 130
2019
Q1
$75K Buy
+1,087
New +$70.2K 0.02% 183
2018
Q4
Sell
-1,087
Closed -$73K 174
2018
Q3
$73K Hold
1,087
0.04% 199
2018
Q2
$70K Hold
1,087
0.05% 163
2018
Q1
$78K Buy
+1,087
New +$78.2K 0.06% 130

Other funds holding CL

Legacy Advisors's CL Position: Q2 2025 in Review

Legacy Advisors sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 3,371 shares — an estimated $316K sold.

Legacy Advisors first reported a position in CL in Q1 2018 and held it in 18 quarters. The position peaked at $367K in Q4 2022. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.

  • Legacy Advisors reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
  • Legacy Advisors sold 3,371 Colgate-Palmolive shares in Q2 2025, an estimated $316K.
  • Legacy Advisors first reported a position in Colgate-Palmolive in Q1 2018 and held it in 18 quarters.
  • Legacy Advisors's Colgate-Palmolive position peaked at $367K in Q4 2022.
  • 1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Legacy Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.